|
▽
|
ARMK |
Aramark |
Industrials |
8.0 |
1.2 |
4.6 |
1 |
13.0 |
15.4 |
2.8 |
2.6 |
18.2 |
-11.08 |
3.6 |
1.04 |
0.92 |
22.01 |
2024-10-23 |
| Aramark provides food and facilities services to education, healthcare, business and industry, sports, leisure, and corrections clients in the United States and internationally. It operates through two segments, Food and Support Services United States, and Food and |
|
▽
|
AROC |
Archrock, Inc. |
Energy |
8.5 |
4.1 |
0.5 |
1 |
102.1 |
34.1 |
4.1 |
0.6 |
12.1 |
-3.41 |
10.6 |
1.40 |
0.86 |
32.80 |
2024-10-23 |
| Archrock, Inc. operates as an energy infrastructure company in the United States. It engages in designing, sourcing, owning, installing, operating, servicing, repairing, and maintaining natural gas compression equipment. The company also sells over-the |
|
▽
|
AROW |
Arrow Financial Corporation |
Financial Services |
13.4 |
4.0 |
12.3 |
2 |
60.1 |
15.9 |
1.3 |
1.8 |
7.9 |
-0.19 |
22.5 |
|
|
9.11 |
2024-10-23 |
| Arrow Financial Corporation, a bank holding company, provides commercial and consumer banking, and financial products and services. Its deposit products include demand deposits, interest-bearing checking accounts, savings deposits, time deposits, and other time deposits. The |
|
▽
|
ARQT |
Arcutis Biotherapeutics, Inc. |
Healthcare |
-46.8 |
0.0 |
|
0 |
0.0 |
-3.7 |
11.0 |
-2.2 |
-295.6 |
-96.91 |
|
7.08 |
6.80 |
25.97 |
2024-10-23 |
| Arcutis Biotherapeutics, Inc. focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials |
|
▽
|
ARR |
ARMOUR Residential REIT, Inc. |
Real Estate |
-4.4 |
29.3 |
-16.4 |
0 |
-359.0 |
-14.1 |
0.8 |
-1.4 |
-5.3 |
-23.38 |
108.6 |
|
|
10.30 |
2024-10-23 |
| ARMOUR Residential REIT, Inc. invests in residential mortgage-backed securities (MBS) in the United States. The company has elected to be taxed as a real estate investment trust. |
|
▽
|
ARRY |
Array Technologies, Inc. |
Technology |
-17.8 |
0.0 |
|
0 |
0.0 |
7.3 |
1.6 |
0.9 |
22.5 |
-13.92 |
8.7 |
2.48 |
2.00 |
35.77 |
2024-10-23 |
| Array Technologies, Inc. manufactures and sells ground-mounting tracking systems used in solar energy projects. The company operates in two segments, Array Legacy Operations and STI Operations. Its products portfolio includes DuraTrack HZ v3, |
|
▽
|
ARVN |
Arvinas, Inc. |
Healthcare |
53.2 |
0.0 |
|
0 |
0.0 |
-5.0 |
2.8 |
-5.4 |
-55.7 |
-14.50 |
-467.9 |
4.98 |
|
50.59 |
2024-10-23 |
| Arvinas, Inc. engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company engineers proteolysis targeting chimeras (PROTAC) targeted protein degraders. |
|
▽
|
ARW |
Arrow Electronics, Inc. |
Technology |
15.0 |
0.0 |
37.5 |
0 |
0.0 |
7.8 |
1.2 |
17.1 |
15.6 |
-3.94 |
2.7 |
1.39 |
1.00 |
26.72 |
2024-10-23 |
| Arrow Electronics, Inc. provides products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. The company operates in two segments, Global Components and Global Enterprise Computing Solutions. The Global Components segment markets and |
|
▽
|
ARWR |
Arrowhead Pharmaceuticals, Inc. |
Healthcare |
37.6 |
0.0 |
|
0 |
0.0 |
-12.3 |
9.3 |
-1.7 |
-75.7 |
-26.16 |
-85.3 |
3.98 |
|
35.44 |
2024-10-23 |
| Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline include Plozasiran, which is in Phase 2b and one Phase 3 clinical |
|
▽
|
AS |
Amer Sports, Inc. |
Consumer Cyclical |
|
|
|
0 |
|
-44.7 |
-58.2 |
-0.4 |
130.2 |
-17.53 |
-4.8 |
1.49 |
0.80 |
-1.91 |
2024-10-23 |
| Amer Sports, Inc. designs, manufactures, markets, distributes, and sells sports equipment, apparel, footwear, and accessories. It operates through three segments: Technical Apparel, Outdoor Performance, and Ball & Racquet Sports. |